Benzinga's Top Downgrades - AMTD IDEA Group (NYSE:AMTD)

Analysts at Morgan Stanley downgraded

MINDBODY IncMB

from Overweight to Equal-weight. The price target for MINDBODY has been raised from $16.50 to $17. MINDBODY shares closed at $16.76 on Friday. Analysts at Bank of America downgraded

Cosan Limited(USA) CZZ

from Buy to Neutral. The price target for Cosan has been lowered from $8.40 to $3.60. Cosan shares closed at $3.06 on Friday. Needham downgraded

Stryker Corporation SYK

from Buy to Hold. Stryker shares closed at $96.90 on Friday. Analysts at Pacific Crest downgraded

Qorvo Inc QRVO

from Overweight to Sector Perform. Qorvo shares closed at $47.68 on Friday. B. Riley downgraded

DSW Inc. DSW

from Buy to Neutral. DSW shares closed at $26.84 on Friday. Wells Fargo downgraded

TD Ameritrade Holding Corp. AMTD

from Outperform to Market Perform. TD Ameritrade shares closed at $32.44 on Friday. Analysts at Goldman Sachs downgraded

Varian Medical Systems, Inc. VAR

from Neutral to Sell. The price target for Varian Medical Systems has been lowered from $83 to $76. Varian Medical Systems shares closed at $75.27 on Friday. Analysts at BB&T Capital downgraded

Snyder's-Lance IncLNCE

from Buy to Hold. Snyders-Lance shares closed at $35.76 on Friday. Wedbush downgraded

Fibrocell Science IncFCSC

from Outperform to Neutral. The price target for Fibrocell Science has been lowered from $7 to $6. Fibrocell Science shares closed at $4.95 on Friday. Analysts at Global Hunter downgraded

Navistar International CorpNAV

from Accumulate to Neutral. Navistar International shares closed at $13.49 on Friday.

Market News and Data brought to you by Benzinga APIs